Welcome to AASLD.ORG!
We hope that you are enjoying AASLD.org and its new features. In the coming months, we plan to offer even more site features and utilities to better serve you. Please send any ideas to webadvisors@aasld.org.
Breaking News: FDA Advisory Panel Tightens Controls on Acetaminophen Products
June 30: FDA Considers Options to Reduce Overdose with AcetaminophenTimothy J. Davern, MD, William M. Lee, MD, and other AASLD members provided key testimony at this week’s FDA hearings about acetaminophen and its relation to liver toxicity.
For the next two weeks, AASLD members will have priority meeting registration and housing reservations. Also: View the registration brochure.
AASLD is facing unique challenges, and because of this, leadership has had to think strategically ... View the interactive AASLD Strategy Map
Registration now open.
AASLD is launching Liver Week®, a new program format. Your interest and opinions are crucial to the future development of this new program.
Be sure to check out this featured opportunity from our Career Center:
Transplant Coordinator; Thomas Jefferson University Hospital, Philadelphia, PA.
New and Revised Guideline: Primary Biliary Cirrhosis
Guideline Update: Management of Adult Patients with Ascites Due to Cirrhosis
Guideline Update: Hepatitis CVascular Disorders of the Liver
Alcohol and Your Health: The NIAAA has built Rethinking Drinking, a valuable, research-based informative website aimed at anyone who drinks.
Acetaminophen and Liver Injury: The FDA has assembled this Q & A primer on acetaminophen safety for consumers.